59P Datopotamab deruxtecan (Dato-DXd) in patients with previously treated advanced non-small cell lung cancer (NSCLC): Nonsquamous (NSQ) histology in the phase III TROPION-Lung01 trial

N. Girard, I. Okamoto, A.E. Lisberg, E. Pons-Tostivint, R. Cornelissen, M.H. Hong, L. Paz-Ares,D. Vicente Baz, S. Sugawara,M. Cobo Dols, M. Pérol, C. Mascaux, E. Felip, Y. Le Guen, J. Sands, M. Chargualaf, Y. Zhang, P. Howarth, D. Uema,M-J. Ahn

ESMO Open（2024）

引用 0|浏览2